ArticleJournal of Alzheimer's disease reports

Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice.

Frederik W Ott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.